GnRH-Analoga in der reproduktionsmedizin

Translated title of the contribution: GnRH analogues in reproductive medicine

C. Dorn*, G. Griesinger

*Corresponding author for this work
1 Citation (Scopus)


In 1997 the Nobel prize for medicine was awarded for the discovery of the GnRH molecule and its mechanisms. By altering natural GnRH synthetic GnRH analogues can be manufactured which have a higher affinity and a longer half-life. These GnRH analogues can be subdivided into GnRH antagonists and GnRH agonists. These medications can be used where suppression of gonadotrophins and sexual hormones is an important principle of the therapy, e.g. breast cancer. GnRH analogues have been established as the standard medication for suppression of LH levels for ovarian stimulation for IVF/ICSI. Various protocols are available for ART with GnRH analogues.

Translated title of the contributionGnRH analogues in reproductive medicine
Original languageGerman
JournalGynakologische Endokrinologie
Issue number3
Pages (from-to)161-170
Number of pages10
Publication statusPublished - 09.2009


Dive into the research topics of 'GnRH analogues in reproductive medicine'. Together they form a unique fingerprint.

Cite this